According to Biotest 's latest financial reports the company's current EPS (TTM) is -โน24.02. In 2022 the company made an earnings per share (EPS) of -โน73.19 an increase over its 2021 EPS that were of -โน160.05.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน22.71 | -68.98% |
2022 | -โน73.19 | -54.27% |
2021 | -โน160.05 | 99.36% |
2020 | -โน80.28 | 471.15% |
2019 | -โน14.06 | -103.03% |
2018 | โน463.56 | -9663.05% |
2017 | -โน4.85 | -95.43% |
2016 | -โน106.11 | -47.94% |
2015 | -โน203.83 | -468.28% |
2014 | โน55.35 | -42.66% |
2013 | โน96.53 | -8.51% |
2012 | โน105.50 | -31.45% |
2011 | โน153.90 | 30.12% |
2010 | โน118.27 | 36.09% |
2009 | โน86.90 |